Carbon News

Greater Understanding of Cell & Gene Therapies Supports Plan Coverage

The Importance of Claim Payment Integrity

FDA Approves New Therapy for Adults with Recurrent Respiratory Papillomatosis

FDA Approves First Cell-Based Gene Therapy for Rare Skin Disorder

Growth of Value-Based Purchasing For Cell & Gene Therapies

FDA Approves Mesoblast’s First-Of-Its-Kind Cell Therapy

PTC Wins FDA Approval For First Brain-Delivered Gene Therapy Kebilidi

FDA Approves Aucatzyl for Adults with Aggressive Leukemia

Sequoia, IOA Re and Rockport Benefits Form Carbon Stop Loss Solutions

FDA Signs Off on Adaptimmune’s Tecelra